Journal for ImmunoTherapy of Cancer (Nov 2021)

712 Preclinical characterization of GT-00A x IL15: A novel IL-15-based immunocytokine with unique tumor targeting properties

Anika Jaekel,
Patrik Kehler,
Timo Lischke,
Christoph Goletz,
Anke Flechner,
Antje Danielczyk,
Johanna Gellert

Affiliations

Anika Jaekel: Glycotope GmbH, Berlin, Germany
Patrik Kehler: Glycotope GmbH, Berlin, Germany
Timo Lischke: Glycotope GmbH, Berlin, Germany
Christoph Goletz: Glycotope GmbH, Berlin, Germany
Anke Flechner: Glycotope GmbH, Berlin, Germany
Antje Danielczyk: Glycotope GmbH, Berlin, Germany
Johanna Gellert: Glycotope GmbH, Berlin, Germany

DOI: https://doi.org/10.1136/jitc-2021-SITC2021.712
Journal volume & issue: Vol. 9, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal